State SD
Clinical Trials in South Dakota
Recruiting clinical trials with at least one study location in South Dakota. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Dakota
Lung Non-Small Cell Carcinoma (2)Melanoma (2)Malignant Neoplasm (2)Malignant Solid Neoplasm (2)Acute Myeloid Leukemia (2)Chronic Lymphocytic Leukemia (2)Carcinoma, Non-Small-Cell Lung (2)Breast Carcinoma (1)Colorectal Carcinoma (1)Non-Hodgkin Lymphoma (1)Adrenal Gland Pheochromocytoma (1)Carcinoma In Situ (1)
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06655896 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cu...
Condition
Scleroderma, Diffuse
Enrollment
96 pts
Location
United States, Australia, Austria
Sponsor
Novartis Pharmaceuticals
NCT06731907 Phase 2
Recruiting
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additi...
Condition
Non-small Cell Lung Cancer
Enrollment
90 pts
Location
United States, Chile, Greece
Sponsor
Merck Sharp & Dohme LLC
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06227572 N/A
Recruiting
Cognition After OSA Treatment Among Native American People (CATNAP)
Condition
Obstructive Sleep Apnea
Enrollment
140 pts
Location
United States
Sponsor
Washington State University
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06357767 N/A
Recruiting
Smoking Cessation Intervention for American Indian Women Experiencing Intimate P...
Condition
Smoking Cessation
Enrollment
48 pts
Location
United States
Sponsor
Black Hills Center for America
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04831164 N/A
Recruiting
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
Condition
Rotator Cuff Tears
Enrollment
3,500 pts
Location
United States
Sponsor
University of Michigan
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT01793168 N/A
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Dis...
Condition
Rare Disorders
Enrollment
20,000 pts
Location
United States, Australia
Sponsor
Sanford Health